Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Arthur J. Gallagher expands with Australian acquisition

EditorBrando Bricchi
Published 2024-05-06, 02:34 p/m
AJG
-

ROLLING MEADOWS, Ill. - Arthur J. Gallagher & Co., the global insurance brokerage and consulting services firm, has acquired Health Insurance Consultants Australia (HICA), a specialist health insurance consultancy and brokerage serving various clients in Australia. The acquisition was announced today, with the terms of the transaction remaining undisclosed.

HICA, based in Melbourne, Victoria, has been providing its services to corporate clients, small and medium-sized businesses, professional groups, and associations for over 30 years. With this acquisition, the HICA team, including founder Suzanne Still and Jethro Still, will continue to operate from their current location. They will now report to Graham Campbell, who leads Gallagher's employee benefits and HR consulting operations in Australia.

J. Patrick Gallagher, Jr., Chairman and CEO of Arthur J. Gallagher & Co., expressed his enthusiasm for the acquisition, stating, "HICA has a strong record of growth and will enhance our benefits consulting capabilities in Australia." He also extended a warm welcome to the HICA team as part of Gallagher's expanding global presence.

Arthur J. Gallagher & Co. (NYSE:AJG), headquartered in Rolling Meadows, Illinois, operates in approximately 130 countries worldwide. The firm is known for offering a wide range of insurance brokerage, risk management, and consulting services through its owned operations and network of correspondent brokers and consultants.

This strategic move by Arthur J. Gallagher & Co. signifies a further strengthening of their international operations, particularly in the Australian market. It's based on a press release statement and the details of the transaction have not been made public.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

Arthur J. Gallagher & Co.'s (NYSE:AJG) latest acquisition of Health Insurance Consultants Australia (HICA) aligns with the company's impressive track record of growth and its commitment to expanding its global footprint, particularly in the Australian market. As investors consider the potential impact of this strategic move, it's important to look at AJG's financial health and market performance to understand the broader context.

According to InvestingPro data, Arthur J. Gallagher & Co. boasts a market capitalization of 52.16 billion USD, underscoring its significant size and influence in the insurance brokerage sector. The company's Price/Earnings (P/E) ratio currently stands at a high 47.34, but when adjusted for the last twelve months as of Q1 2024, it presents a more favorable figure of 29.17. This adjustment reflects the company's earnings growth and investors' willingness to pay a premium for its shares based on future earnings expectations.

InvestingPro Tips highlight that Arthur J. Gallagher & Co. has raised its dividend for an impressive 13 consecutive years, demonstrating its commitment to returning value to shareholders. Additionally, the company is expected to maintain profitability this year, as indicated by analysts' predictions. This financial stability is also reflected in the company's revenue growth of 18.67% over the last twelve months as of Q1 2024, suggesting a robust business model capable of generating increased sales.

For investors looking for more insights and analysis, there are additional InvestingPro Tips available on the platform. To explore these further, visit https://www.investing.com/pro/AJG and don't forget to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With these tools at your disposal, you'll be better equipped to make informed investment decisions regarding Arthur J. Gallagher & Co. and its recent expansion efforts.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.